Business
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS
GENEVA, May 13, 2025--Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS
About this update from Alcon Ag
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":202,"url":"https://media.zenfs.com/en/business-wire.com/a3c29c82f2a0d29640d2628b52866532"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/r6C59AL0HHoZSd.ICuypog--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQwNDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a3c29c82f2a0d29640d2628b52866532","width":480,"height":202}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"First-quarter 2025 sales of $2.5 billion, in line on a reported basis, or up 3% constant currency1 (cc), versus first-quarter 2024","length":130,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"First-quarter 2025 diluted EPS of $0.70; core diluted EPS2 of $0.73","length":67,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Generated $384 million cash from operations and $278 million free cash flow3","length":76,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Dividend of CHF 0.28 per share approved by shareholders at the Annual General Meeting on May 6, 2025","length":100,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Launched rich pipeline of innovative products, including Voyager, Precision7 and Systane Pro PF in Q1 2025; Unity VCS and PanOptix Pro in May 2025","length":146,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":519,"olType":false},{"type":"text","content":"Ad Hoc Announcement Pursuant to Art. 53 LR","length":42,"tagName":"p"},{"type":"text","content":"GENEVA, May 13, 2025--(BUSINESS WIRE)--Regulatory News:","length":55,"tagName":"p"},{"type":"text","content":"Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ending March 31, 2025. For the first quarter of 2025, sales were $2.5 billion, flat on a reported basis and up 3% on a constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.70 and core diluted earnings per share2 of $0.73 in the first quarter of 2025.","length":430,"tagName":"p"},{"type":"text","content":""Despite a soft US market, I am excited about the strong initial customer reception to our recent product launches, including Unity VCS, PanOptix Pro, Voyager, Preci...